Unichem Laboratories Ltd.

₹488.8

7.7 (1.6%)

UNICHEMLAB Share Price

Pharmaceuticals & Biotechnology

As on October 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 3,425.59 Cr

P/E Ratio13.61

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	481.05	Bullish
10-DMA	496.57	Bearish
20-DMA	517.93	Bearish
50-DMA	531.75	Bearish
100-DMA	517.32	Bearish
200-DMA	439.05	Bullish

Historical Performance

1 Year

3 Years

10.4%

5 Years

97.9%

10 Years

67.8%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	22,019	21,110	17,851	13,430	12,698
Total Expenditure	20,177	18,461	16,982	13,886	11,970
Other Income	631	353	316	385	475
Operating Profit	2,472	3,002	1,185	-70	1,203
Interest	316	210	227	173	61
Depreciation	1,251	1,246	1,232	1,134	912
Profit Before Tax	2,924	1,546	-850	-1,764	220
Consolidated Net Profit	2,528	1,375	-938	-2,022	331
Adjusted EPS	36	20	-13	-29	5

Compounded Sales Growth

10 Years:10.6

5 Years:12.3

3 Years:10.4

TTM:0.8

Compounded Profit Growth

10 Years:18.5

5 Years:49.1

3 Years:-15.4

TTM:13

Stock Price CAGR

10 Years:5.3

5 Years:15.3

3 Years:3.4

TTM:3.4

Return on Equity

10 Years:12

5 Years:4.7

3 Years:-13.3

last year:35.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	141	141	141	141	141
Total Reserves	26,974	24,314	24,212	24,092	25,936
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,035	987	923	1,080	1,439
Other Current Liabilities	1,092	1,228	930	1,283	1,351
Short Term Borrowings	4,154	3,403	1,553	2,081	2,157
Total Liabilities	37,069	35,436	32,682	31,829	33,144
Capital Work in Progress	1,001	307	1,227	1,475	4,938
Long Term Loans & Advances	1,936	1,506	1,249	1,681	1,656
Currents Investments	---	---	13	15	2,636
Short Term Loans and Advances	664	1,016	1,755	1,564	1,381
Total Current Assets	21,973	20,295	17,433	15,885	16,449
Total Assets	37,069	35,436	32,682	31,829	33,144
Adjusted Book Value	385	347	346	344	370

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 13.61, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a weak 3-year price CAGR of 3.6%, indicating poor shareholder returns.
The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹2472 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹22019 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1034169

No. of Shares: 2116 (Approx)

Performance:3.4%

34169

NIFTY Performance: -12.9%

1 day Top Gainers